Cargando…
Targeted approaches to improve outcomes for highest-cost patients
Bash and colleagues, using data from Maccabi Healthcare Services, have documented increased cost and utilization attributable to patients with congestive heart failure (CHF). The CHF patients were older than the general population and had high rates of important comorbid conditions. While it is some...
Autor principal: | Rose, Adam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461745/ https://www.ncbi.nlm.nih.gov/pubmed/28593037 http://dx.doi.org/10.1186/s13584-017-0151-6 |
Ejemplares similares
-
‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
por: Annemans, Lieven, et al.
Publicado: (2018) -
Pushing the limits for the highest critical currents in superconductors
por: Civale, Leonardo
Publicado: (2019) -
Commentary: Protecting the artery of Adamkiewicz: Highest imperative
por: Falasa, Matheus P., et al.
Publicado: (2021) -
Canada’s highest court unchains injection drug users; implications for harm reduction as standard of healthcare
por: Small, Dan
Publicado: (2012) -
How Did We Get Here: The Best Vaccines Ever Facing the Highest Public Hesitancy?
por: Ferreccio, Catterina
Publicado: (2023)